KDA GROUP Aktie

 

  Thetford Mines, Quebec – TheNewswire - December 3, 2024 – KDA Group Inc. (TSXV: KDA) (“KDA” or the “Corporation”), a leader in innovative technological solutions for healthcare professionals, is pleased to announce an important update regarding our progress towards certification with the Québec Health Record / Dossier Santé Québec (“DSQ”), the province-wide platform enabling the secure exchange of prescriptions, laboratory results, and imaging between healthcare professionals and patients for our project Medherize. As part of our commitment to integrating with the DSQ, we have successfully completed the development of all required functionalities for the first phase of the certification process. This represents a significant technical milestone, as the first phase is a critical component in ensuring that our application meets the stringent requirements for accessing the DSQ. We have also initiated work on the second phase of the certification, further demonstrating our dedication to ...

  Thetford Mines, Quebec – TheNewswire - November 21, 2024 – KDA Group Inc. (TSXV: KDA) (“KDA” or the “Corporation”), a leader in innovative technological solutions for healthcare professionals, is proud to announce the appointment of the Honorable Jean Charest as the Corporation's new Strategic Advisor. This milestone marks a significant step in the strategic development of KDA as it continues its commitment to redefining the future of healthcare through digital innovation. Mr. Jean Charest, former Premier of Québec (2003-2012) and former Deputy Prime Minister of Canada (1993), brings invaluable expertise in governance, public policy, and international affairs. With his distinguished career and current role as Strategic Advisor at the law firm Therrien Couture Joli-Coeur, Mr. Charest will guide KDA in its growth and expansion initiatives on both national and international scales. Marc Lemieux, Chief Executive Officer and Chairman of the Board of KDA, stated: “We are honored to welcome Mr...

  Thetford Mines, Quebec – TheNewswire - August 1, 2024 – KDA Group Inc. (TSXV: KDA) (“KDA” or the “Corporation”), announces the launch of Medherize, an innovative initiative to improve the management of specialized treatments for metastatic breast cancer. Developed in collaboration with doctors, pharmacists and patients, this platform aims to enhance the quality of care and support for healthcare professionals and patients. Support for Healthcare Professionals Medherize helps healthcare professionals better manage treatments for patients with breast cancer. The platform offers tools to track treatment adherence, manage side effects and optimize care plans, facilitating an integrated and personalized approach. Impact on Patients Medherize provides patients with clear information about their treatments, reminders for appointments and medications, and access to support resources, helping them feel more autonomous and supported in their fight against cancer. Current Challenges in Breast Cancer T...